Utilidad del índice Leucoglicémico como predictor de muerte en pacientes con infarto agudo de Miocardio

Introducción: El índice leuco glicémico un parámetro simple ha evidenciado relieve pronostico en pacientes con IAM (infarto agudo de miocardio); este siendo un marcado reciente carece en sí de estudios que comprueben al cien por ciento su utilidad. Objetivo: Evaluar el índice leuco glucémico como predictor de muerte en pacientes con IAM. Métodos: Se elaboró un estudio de casos y controles en 82 pacientes con IAM que ingresaron entre enero del 2013 y diciembre del 2017 en el servicio de Medicina Interna del Hospital de Chancay. Se recogieron tanto datos clínicos como de laboratorio, donde se separarán los casos y posteriormente los controles, los cuales serán pareados según edad y sexo, en donde se determinará de forma manual el ILG del primer hemograma y la primera glicemia que figure en emergencia o admisión. Resultados: Conclusiones: El índice leucoglicémico >1490 es predictor de muerte en pacientes con infarto agudo de miocardio, tiene 88.89 y 69.84% de sensibilidad y especificidad para muerte por infarto agudo de miocardio, respectivamente. El índice leucoglicémico tiene 45.71 y 95.65% de valor predictivo positivo y negativo para muerte por infarto agudo de miocardio. El punto de corte del índice leucoglicémico como pronóstico de muerte en pacientes con infarto agudo de miocardio es de 1490

Utilidad del índice Leucoglicémico como predictor de muerte en pacientes con infarto agudo de Miocardio

Introducción: El índice leuco glicémico un parámetro simple ha evidenciado relieve pronostico en pacientes con IAM (infarto agudo de miocardio); este siendo un marcado reciente carece en sí de estudios que comprueben al cien por ciento su utilidad. Objetivo: Evaluar el índice leuco glucémico como predictor de muerte en pacientes con IAM. Métodos: Se elaboró un estudio de casos y controles en 82 pacientes con IAM que ingresaron entre enero del 2013 y diciembre del 2017 en el servicio de Medicina Interna del Hospital de Chancay. Se recogieron tanto datos clínicos como de laboratorio, donde se separarán los casos y posteriormente los controles, los cuales serán pareados según edad y sexo, en donde se determinará de forma manual el ILG del primer hemograma y la primera glicemia que figure en emergencia o admisión. Resultados: Conclusiones: El índice leucoglicémico >1490 es predictor de muerte en pacientes con infarto agudo de miocardio, tiene 88.89 y 69.84% de sensibilidad y especificidad para muerte por infarto agudo de miocardio, respectivamente. El índice leucoglicémico tiene 45.71 y 95.65% de valor predictivo positivo y negativo para muerte por infarto agudo de miocardio. El punto de corte del índice leucoglicémico como pronóstico de muerte en pacientes con infarto agudo de miocardio es de 1490

Safety of hospital discharge before return of bowel function after elective colorectal surgery

Background: Ileus is common after colorectal surgery and is associated with an increased risk of postoperative complications. Identifying features of normal bowel recovery and the appropriateness for hospital discharge is challenging. This study explored the safety of hospital discharge before the return of bowel function.Methods: A prospective, multicentre cohort study was undertaken across an international collaborative network. Adult patients undergoing elective colorectal resection between January and April 2018 were included. The main outcome of interest was readmission to hospital within 30 days of surgery. The impact of discharge timing according to the return of bowel function was explored using multivariable regression analysis. Other outcomes were postoperative complications within 30 days of surgery, measured using the Clavien-Dindo classification system.Results: A total of 3288 patients were included in the analysis, of whom 301 (9.2 per cent) were discharged before the return of bowel function. The median duration of hospital stay for patients discharged before and after return of bowel function was 5 (i.q.r. 4-7) and 7 (6-8) days respectively (P < 0.001). There were no significant differences in rates of readmission between these groups (6.6 versus 8.0 per cent; P = 0.499), and this remained the case after multivariable adjustment for baseline differences (odds ratio 0.90, 95 per cent c.i. 0.55 to 1.46; P = 0.659). Rates of postoperative complications were also similar in those discharged before versus after return of bowel function (minor: 34.7 versus 39.5 per cent; major 3.3 versus 3.4 per cent; P = 0.110).Conclusion: Discharge before return of bowel function after elective colorectal surgery appears to be safe in appropriately selected patients

Timing of nasogastric tube insertion and the risk of postoperative pneumonia: an international, prospective cohort study

Aim: Aspiration is a common cause of pneumonia in patients with postoperative ileus. Insertion of a nasogastric tube (NGT) is often performed, but this can be distressing. The aim of this study was to determine whether the timing of NGT insertion after surgery (before versus after vomiting) was associated with reduced rates of pneumonia in patients undergoing elective colorectal surgery. Method: This was a preplanned secondary analysis of a multicentre, prospective cohort study. Patients undergoing elective colorectal surgery between January 2018 and April 2018 were eligible. Those receiving a NGT were divided into three groups, based on the timing of the insertion: routine NGT (inserted at the time of surgery), prophylactic NGT (inserted after surgery but before vomiting) and reactive NGT (inserted after surgery and after vomiting). The primary outcome was the development of pneumonia within 30 days of surgery, which was compared between the prophylactic and reactive NGT groups using multivariable regression analysis. Results: A total of 4715 patients were included in the analysis and 1536 (32.6%) received a NGT. These were classified as routine in 926 (60.3%), reactive in 461 (30.0%) and prophylactic in 149 (9.7%). Two hundred patients (4.2%) developed pneumonia (no NGT 2.7%; routine NGT 5.2%; reactive NGT 10.6%; prophylactic NGT 11.4%). After adjustment for confounding factors, no significant difference in pneumonia rates was detected between the prophylactic and reactive NGT groups (odds ratio 1.03, 95% CI 0.56–1.87, P = 0.932). Conclusion: In patients who required the insertion of a NGT after surgery, prophylactic insertion was not associated with fewer cases of pneumonia within 30 days of surgery compared with reactive insertion